SCHEMBL2272453

SCHEMBL2272453

O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)c1ccccc1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 7/20 0.63
KCNMA1 Q12791 2/20 0.62
HDAC1 Q13547 2/20 0.60
DHODH Q02127 1/20 0.57
ACMSD Q8TDX5 3/20 0.57
LMNA P02545 3/20 0.57
HTT P42858 3/20 0.57
HNF4A P41235 2/20 0.57
TP53 P04637 2/20 0.57
DHFR P00374 1/20 0.57
MCL1 Q07820 1/20 0.57
NPC1 O15118 1/20 0.57
GAA P10253 1/20 0.57
HDAC2 Q92769 1/20 0.56
SUCNR1 Q9BXA5 1/20 0.53
KDM4E B2RXH2 2/20 0.53
HPGD P15428 2/20 0.53
HSD17B10 Q99714 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1320352 0.93 ACMSD (0.68) ACLYKCNMA1HDAC1DHODHACMSD
SCHEMBL1318525 0.91 ACLY (0.67) ACLYKCNMA1HDAC1DHODHACMSD
SCHEMBL27696863 0.90 ACLY (0.62) ACLYKCNMA1HDAC1SUCNR1
SCHEMBL13206537 0.87 ACLY (0.59) ACLYKCNMA1HDAC1DHODHACMSD
SCHEMBL13206516 0.87 ACLY (0.61) ACLYHDAC1DHODHACMSDHNF4A
SCHEMBL1316633 0.86 ACLY (0.57) ACLYHDAC1DHODHACMSDLMNA
SCHEMBL1317521 0.86 ACLY (0.68) ACLYKCNMA1ACMSDHNF4ASUCNR1
SCHEMBL2272508 0.85 ACLY (0.63) ACLYHDAC1DHODHHTTSUCNR1
SCHEMBL1315890 0.85 ACLY (0.67) ACLYKCNMA1HDAC1ACMSDHNF4A
SCHEMBL13206145 0.85 ACLY (0.56) ACLYKCNMA1HDAC1DHODHACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094829-B novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO.,LTD. (JP) 2012-02-08 CN disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
CN-101094829-A Novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 2007-12-26 CN disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 ACLY 653/4885KCNMA1 2049/4885HDAC1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.